Reversal of the estrogen receptor-negative phenotype in breast cancer and restoration of antiestrogen response

Keyphrases

• Breast Cancer 100%
• Estrogen Receptor 100%
• Antiestrogen 100%
• Estrogen Receptor-negative 100%
• Mitogen-activated Protein Kinase 33%
• Breast Cancer Cell Lines 19%
• Re-expression 19%
• Tumor 14%
• Epidermal Growth Factor Receptor 9%
• Estrogen Receptor Status 9%
• U0126 9%
• Protein Kinase Inhibitors 9%
• C-erbB-2 9%
• Western Blotting 4%
• Breast Cancer Patients 4%
• Quantitative PCR 4%
• Overexpression 4%
• Breast Tumor 4%
• Herceptin 4%
• Receptor-interacting Protein Kinase 1 (RIPK1) 4%
• Estrogen Therapy 4%
• Hyperactivity 4%
• Protein Kinase Activity 4%
• Better Prognosis 4%
• Tumor Specimens 4%
• Growth Assay 4%
• Epithelial Cultures 4%
• Iressa 4%
• Mitogen-activated Protein Kinase Inhibitor 4%
• Hormonal Therapy 4%
• Tumor Cell Culture 4%
• WST-1 4%
• Cell Tumor 4%

Medicine and Dentistry

• Breast Cancer 100%
• Antiestrogen 100%
• Estrogen Receptor 100%
• Mitogen-Activated Protein Kinase 29%
• Neoplasm 20%
• Breast Cancer Cell Line 16%
• Receptor Expression 8%
• Epidermal Growth Factor Receptor 8%
• U0126 8%
• Breast Tumor 4%
• Hormone Therapy 4%
• Western Blot 4%
• Gefitinib 4%
• Hyperactivation 4%
• Tumor Cell Culture 4%
• Mitogen Activated Protein Kinase Inhibitor 4%
• Cell Line 4%
• Trastuzumab 4%
• Messenger RNA 4%
• Reverse Transcription Polymerase Chain Reaction 4%

Pharmacology, Toxicology and Pharmaceutical Science

• Estrogen Receptor 100%
• Breast Cancer 100%
• Antiestrogen 100%
• Mitogen Activated Protein Kinase 29%
• Neoplasm 25%
• 1,4 Diamino 1,4 Bis(2 Aminophenylthio) 2,3 Dicyanobutadiene 8%
• Epidermal Growth Factor Receptor 8%
• Cell Culture 4%
• Western Blot 4%
• Hormone Cancer Therapy 4%
• Breast Tumor 4%
• Gefitinib 4%
• Mitogen Activated Protein Kinase Inhibitor 4%
• Trastuzumab 4%
• Messenger RNA 4%